CoChat

Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Stem cell-derived cardiomyocytes and vascular cells can be used for a variety of applications such as studying human heart development and modelling human disease in culture. In particular, protocols based on modulation of Wnt signaling were able to produce high quality of cardiomyocytes or vascular cells from human pluripotent stem cells (hPSCs). However, the mechanism behind the development of 3D cardiovascular spheroids into either vascular or cardiac cells has not been well explored. Hippo/Yes-associated protein (YAP) signaling plays important roles in the regulation of organogenesis, but its impact on cardiovascular differentiation has been less evaluated. In this study, the effects of seeding density and a change in YAP signaling on 3D cardiovascular spheroids patterning from hPSCs were evaluated. Compared to 2D culture, 3D cardiovascular spheroids exhibited higher levels of sarcomeric striations and higher length-to-width ratios of α-actinin+ cells. The spheroids with high seeding density exhibited more α-actinin+ cells and less nuclear YAP expression. The 3D cardiovascular spheroids were also treated with different small molecules, including Rho kinase inhibitor (Y27632), Cytochalasin D, Dasatinib, and Lysophosphatidic acid to modulate YAP localization. Nuclear YAP inhibition resulted in lower expression of active β-catenin, vascular marker, and MRTF, the transcription factor mediated by RhoGTPases. Y27632 also promoted the gene expression of MMP-2/-3 (matrix remodeling) and Notch-1 (Notch signaling). These results should help our understanding of the underlying effects for the efficient patterning of cardiovascular spheroids after mesoderm formation from hPSCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-37686-1

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cardiac differentiation from hiPSCs on monolayer culture (2D). (A) (i) Representative fluorescent images of cardiac markers: Nkx2.5, α-actinin for cells at day 15; (ii) Representative fluorescent images of cardiac marker- α-actinin for cells at day 37. Scale bar: 100 μm. (B) A schematic differentiation timeline using CHIR99021 (CH) and IWP4. (C) The expression of cardiac markers Nkx2.5 and α-actinin for CHIR99021 treatment conditions analyzed by flow cytometry: isotypes (i), 5 µM 24 hours (ii), 5 µM 48 hours (iii), 10 µM 24 hours (iv) and 10 µM 48 hours (v) for samples at day 13. (D) Activin A/BMP-4 induced differentiation (day 18): Isotype control and α-actinin expression.
Figure 1 Cardiac differentiation from hiPSCs on monolayer culture (2D). (A) (i) Representative fluorescent images of cardiac markers: Nkx2.5, α-actinin for cells at day 15; (ii) Representative fluorescent images of cardiac marker- α-actinin for cells at day 37. Scale bar: 100 μm. (B) A schematic differentiation timeline using CHIR99021 (CH) and IWP4. (C) The expression of cardiac markers Nkx2.5 and α-actinin for CHIR99021 treatment conditions analyzed by flow cytometry: isotypes (i), 5 µM 24 hours (ii), 5 µM 48 hours (iii), 10 µM 24 hours (iv) and 10 µM 48 hours (v) for samples at day 13. (D) Activin A/BMP-4 induced differentiation (day 18): Isotype control and α-actinin expression.CC BY · PubMed Central
Figure 2 Cardiac spheroid formation and maturation from hiPSCs in 3D culture. (A) The level of sarcomeric striations was visualized from high-magnification images and given a score of 1–4. Cells that received a score of 1 stained positively for α-actinin, but without clear sarcomeric striations. Cells that were scored 2,3, or 4 had detectable sarcomeric striations at increasing levels. Scale bar: 50 μm. (B) The phase contrast images of cardiac spheres at day 3 and day 7 after initial formation at day 15, and representative fluorescent images of cardiac marker-α-actinin for cardiac spheroids at day 35. (C) The expression of α-actinin of 3D samples: isotype (i), parallel 2D (ii), and 3D (iii) by flow cytometry. (D) Representative fluorescent image and the enlarged image of cardiac markers: Nkx2.5 and α-actinin for 3D samples at day 35. Scale bar: 100 μm. Hoe: Hoechst 33342. (E) Percentage of cells by the scores. Note that cells from 3D cultures displayed higher numbers of cells with more clear sarcomeric striations compared with cells from 2D cultures.
Figure 2 Cardiac spheroid formation and maturation from hiPSCs in 3D culture. (A) The level of sarcomeric striations was visualized from high-magnification images and given a score of 1–4. Cells that received a score of 1 stained positively for α-actinin, but without clear sarcomeric striations. Cells that were scored 2,3, or 4 had detectable sarcomeric striations at increasing levels. Scale bar: 50 μm. (B) The phase contrast images of cardiac spheres at day 3 and day 7 after initial formation at day 15, and representative fluorescent images of cardiac marker-α-actinin for cardiac spheroids at day 35. (C) The expression of α-actinin of 3D samples: isotype (i), parallel 2D (ii), and 3D (iii) by flow cytometry. (D) Representative fluorescent image and the enlarged image of cardiac markers: Nkx2.5 and α-actinin for 3D samples at day 35. Scale bar: 100 μm. Hoe: Hoechst 33342. (E) Percentage of cells by the scores. Note that cells from 3D cultures displayed higher numbers of cells with more clear sarcomeric striations compared with cells from 2D cultures.CC BY · PubMed Central
Figure 3 Measurements of sarcomeric lengths and morphology of cardiomyocytes. (A) Representative fluorescent image of cardiac marker α-actinin for 2D and 3D cultures. Scale bar: 100 μm. (B) The sarcomere length of cells for different samples. (C) The length/width ratio of cells for different samples. (D) Representative fluorescent image and enlarge image of cardiac markers Nkx2.5, α-actinin and vascular markers CD31 and VE-cadherin for 3D samples at day 35. Scale bar: 100 μm. *Indicates p < 0.05.
Figure 3 Measurements of sarcomeric lengths and morphology of cardiomyocytes. (A) Representative fluorescent image of cardiac marker α-actinin for 2D and 3D cultures. Scale bar: 100 μm. (B) The sarcomere length of cells for different samples. (C) The length/width ratio of cells for different samples. (D) Representative fluorescent image and enlarge image of cardiac markers Nkx2.5, α-actinin and vascular markers CD31 and VE-cadherin for 3D samples at day 35. Scale bar: 100 μm. *Indicates p < 0.05.CC BY · PubMed Central
Figure 4 Cell density effects on cardiovascular spheroid formation from hiPSCs. (A) Representative fluorescent images of cardiovascular markers CD31 and VE-cadherin for different seeding densities at day 22. Scale bar: 100 μm. (B) The quantitative analysis of CD31 and VE-cadherin positive cells (by ImageJ analysis). (C) The representative expression of CD31, VE-cadherin and α-actinin by flow cytometry. Black line: negative control; Red line: marker of interest.
Figure 4 Cell density effects on cardiovascular spheroid formation from hiPSCs. (A) Representative fluorescent images of cardiovascular markers CD31 and VE-cadherin for different seeding densities at day 22. Scale bar: 100 μm. (B) The quantitative analysis of CD31 and VE-cadherin positive cells (by ImageJ analysis). (C) The representative expression of CD31, VE-cadherin and α-actinin by flow cytometry. Black line: negative control; Red line: marker of interest.CC BY · PubMed Central
Figure 5 Cell density effects on YAP expression from hiPSCs. (A) Representative fluorescent images of markers α-actinin and YAP for different seeding densities (1 × 104, 2 × 104, 5 × 104 initial cells/spheroid in each well of 96-well plate) at day 18. Scale bar: 100 μm. (B) The quantitative analysis of nuclear and cytoplasmic YAP expression. *Indicates p < 0.05.
Figure 5 Cell density effects on YAP expression from hiPSCs. (A) Representative fluorescent images of markers α-actinin and YAP for different seeding densities (1 × 104, 2 × 104, 5 × 104 initial cells/spheroid in each well of 96-well plate) at day 18. Scale bar: 100 μm. (B) The quantitative analysis of nuclear and cytoplasmic YAP expression. *Indicates p < 0.05.CC BY · PubMed Central
Figure 6 The effects of Cytochalasin D (CytoD) and ROCK inhibitor Y27632 (ROCKi) on cardiovascular spheroids formation. (A) (i) Representative fluorescent images of CD31 expression for CytoD (5 µM) and Y27632 (10 µM) treatment for 5 days after 15 day-differentiation. Scale bar: 100 μm. (ii) The quantitative analysis of CD31 (by image analysis). (B) The expression of CD31 and VE-cadherin by flow cytometry. (C) (i) Representative fluorescent images of YAP localization for CytoD (5 µM) and Y27632 (10 µM) treatment; (ii) The quantitative analysis of nuclear and cytoplasmic YAP expression (by image analysis). * and **indicate p < 0.05. (D) The expression of active β-catenin by flow cytometry. Black line: negative control; Red line: marker of interest.
Figure 6 The effects of Cytochalasin D (CytoD) and ROCK inhibitor Y27632 (ROCKi) on cardiovascular spheroids formation. (A) (i) Representative fluorescent images of CD31 expression for CytoD (5 µM) and Y27632 (10 µM) treatment for 5 days after 15 day-differentiation. Scale bar: 100 μm. (ii) The quantitative analysis of CD31 (by image analysis). (B) The expression of CD31 and VE-cadherin by flow cytometry. (C) (i) Representative fluorescent images of YAP localization for CytoD (5 µM) and Y27632 (10 µM) treatment; (ii) The quantitative analysis of nuclear and cytoplasmic YAP expression (by image analysis). * and **indicate p < 0.05. (D) The expression of active β-catenin by flow cytometry. Black line: negative control; Red line: marker of interest.CC BY · PubMed Central
Figure 7 Characterizations of tight junction protein, cell-cell communication, and matrix remodeling proteins. (A) (i) Flow cytometry histograms of tight junction protein ZO-1. Black line: negative control; Red line: marker of interest. (ii) Quantification of ZO-1 expression by flow cytometry (n = 3) for different seeding densities, and for (iii) CytoD and Y27632 treated cells seeded with 5.0 × 104 initial cells/spheroid in each well of 96-well plate. (B) RT-PCR analysis of MMP2, MMP3, and Notch-1 gene expression for CytoD and Y27632 treatments. (C) RT-PCR analysis of MRTF and CTGF gene expression for Dasatinib and Lysophosphatidic acid (LPA) treatments. *Indicates p < 0.05.
Figure 7 Characterizations of tight junction protein, cell-cell communication, and matrix remodeling proteins. (A) (i) Flow cytometry histograms of tight junction protein ZO-1. Black line: negative control; Red line: marker of interest. (ii) Quantification of ZO-1 expression by flow cytometry (n = 3) for different seeding densities, and for (iii) CytoD and Y27632 treated cells seeded with 5.0 × 104 initial cells/spheroid in each well of 96-well plate. (B) RT-PCR analysis of MMP2, MMP3, and Notch-1 gene expression for CytoD and Y27632 treatments. (C) RT-PCR analysis of MRTF and CTGF gene expression for Dasatinib and Lysophosphatidic acid (LPA) treatments. *Indicates p < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 27

Metadata

Authors
Yan, Y., Bejoy, J., Xia, J., Griffin, K., Guan, J., & Li, Y.
Affiliations
Florida State University (US)
Corresponding author
Li, Yan
Venue
Scientific Reports
Published
2019-02-04
Volume
9
Issue
1
Pages
1295-1295
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2917220793
Cited by
27
References
70
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 10 · 2020: 11 · 2019: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Science Foundation (1652992, CAREER)
  • Directorate for Biological Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
human induced pluripotent stem cells, YAP signaling, Hippo signaling pathway, cardiomyocyte differentiation, vascular differentiation, seeding rate, Wnt signaling, Rho kinase inhibition, Y-27632, cytochalasin D, dasatinib, lysophosphatidic acid, β-catenin, Notch signaling, MRTF, matrix remodeling, mesoderm formation
MeSH terms
Cell Communication, Cell Differentiation, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Biomarkers, Gene Expression, Spheroids, Cellular, Cell Culture Techniques, Matrix Metalloproteinases, Myocytes, Cardiac, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells. https://app.cochat.ai/papers/10.1038/s41598-018-37686-1
The paper
Yan, Y., Bejoy, J., Xia, J., Griffin, K., Guan, J., & Li, Y. (2019). Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells. Scientific Reports. https://doi.org/10.1038/s41598-018-37686-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.